140 related articles for article (PubMed ID: 38356609)
1. Prognostic impact of coexisting cardiovascular disease in patients with cancer: A multicenter retrospective cohort study.
Kuwabara Y; Morishima T; Kudo H; Ma C; Kato MS; Koyama S; Nakata K; Tabuchi T; Miyashiro I
Heliyon; 2024 Feb; 10(3):e25594. PubMed ID: 38356609
[TBL] [Abstract][Full Text] [Related]
2. Impact of coexisting diabetes on survival and risk of developing second primary cancer in diabetes patients receiving drug therapy: A multicenter retrospective cohort study of patients with cancer in Japan.
Kuwabara Y; Morishima T; Odani S; Kudo H; Ma C; Kato M; Koyama S; Saito MK; Nakata K; Tabuchi T; Miyashiro I
J Diabetes Investig; 2023 Feb; 14(2):329-338. PubMed ID: 36345271
[TBL] [Abstract][Full Text] [Related]
3. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.
Liu C; Lai Y; Wu D; Fu R; Li Y; Li H; Guan T; Shen Y
ESC Heart Fail; 2021 Dec; 8(6):5338-5351. PubMed ID: 34545695
[TBL] [Abstract][Full Text] [Related]
4. Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Rohde LE; Zimerman A; Vaduganathan M; Claggett BL; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
JAMA Cardiol; 2023 Feb; 8(2):150-158. PubMed ID: 36477809
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure: a retrospective study.
Liu C; Lai Y; Guan T; Shen Y; Pan Y; Wu D
ESC Heart Fail; 2020 Dec; 7(6):3929-3941. PubMed ID: 32945144
[TBL] [Abstract][Full Text] [Related]
6. Time to Death and Its Determinant Factors Among Patients With Chronic Heart Failure in Northwest Ethiopia: A Retrospective Study at Selected Referral Hospitals.
Moyehodie YA; Muluneh MW; Belay AT; Fenta SM
Front Cardiovasc Med; 2022; 9():817074. PubMed ID: 35600464
[TBL] [Abstract][Full Text] [Related]
7. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
Europace; 2023 May; 25(5):. PubMed ID: 37078691
[TBL] [Abstract][Full Text] [Related]
8. Assessment of risk factors for mortality in patients with cardiovascular disease and a history of treatment for malignancy.
Rydzek J; Gąsior ZT; Dąbek J; Wojnar J; Skrzypek M
Kardiol Pol; 2015; 73(9):730-9. PubMed ID: 26390319
[TBL] [Abstract][Full Text] [Related]
9. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
[TBL] [Abstract][Full Text] [Related]
11. Coexisting morbidity burden in elderly hospitalized patients with and without heart failure.
Simou A; Xanthopoulos A; Giamouzis G; Papagiannis D; Dimos A; Economou D; Skoularigis J; Triposkiadis F
Hellenic J Cardiol; 2022; 65():53-55. PubMed ID: 35158053
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognosis of patients with heart failure in Tokyo: a prospective cohort of Shinken Database 2004-5.
Goda A; Yamashita T; Suzuki S; Ohtsuka T; Uejima T; Oikawa Y; Yajima J; Koike A; Nagashima K; Kirigaya H; Sagara K; Ogasawara K; Isobe M; Sawada H; Aizawa T
Int Heart J; 2009 Sep; 50(5):609-25. PubMed ID: 19809210
[TBL] [Abstract][Full Text] [Related]
13. A propensity-matched study of the association of physical function and outcomes in geriatric heart failure.
Ahmed A; Aronow WS
Arch Gerontol Geriatr; 2008; 46(2):161-72. PubMed ID: 17532064
[TBL] [Abstract][Full Text] [Related]
14. Impact of Cardiovascular Disease on the Death Certificate Diagnosis of Heart Failure, Ischemic Heart Disease, and Cerebrovascular Disease - The Japan Public Health Center-Based Prospective Study.
Saito I; Yamagishi K; Kokubo Y; Yatsuya H; Iso H; Sawada N; Inoue M; Tsugane S
Circ J; 2023 Aug; 87(9):1196-1202. PubMed ID: 36948630
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
Polovina M; Lund LH; Đikić D; Petrović-Đorđević I; Krljanac G; Milinković I; Veljić I; Piepoli MF; Rosano GMC; Ristić AD; Ašanin M; Seferović PM
Eur J Heart Fail; 2020 Jan; 22(1):113-125. PubMed ID: 31822042
[TBL] [Abstract][Full Text] [Related]
16. Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.
Kaur P; Saxena N; You AX; Wong RCC; Lim CP; Loh SY; George PP
BMJ Open; 2018 May; 8(5):e021291. PubMed ID: 29780030
[TBL] [Abstract][Full Text] [Related]
17. Association of ischemic heart disease with long-term risk of cognitive decline and dementia: A cohort study.
Imahori Y; Vetrano DL; Ljungman P; Laukka EJ; Wu J; Grande G; Rizzuto D; Fratiglioni L; Qiu C
Alzheimers Dement; 2023 Dec; 19(12):5541-5549. PubMed ID: 37249150
[TBL] [Abstract][Full Text] [Related]
18. Trends in Cause-Specific Outcomes Among Individuals With Type 2 Diabetes and Heart Failure in the United Kingdom, 1998-2017.
Lawson CA; Zaccardi F; McCann GP; Davies MJ; Kadam UT; Khunti K
JAMA Netw Open; 2019 Dec; 2(12):e1916447. PubMed ID: 31790564
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
Magnani G; Giugliano RP; Ruff CT; Murphy SA; Nordio F; Metra M; Moccetti T; Mitrovic V; Shi M; Mercuri M; Antman EM; Braunwald E
Eur J Heart Fail; 2016 Sep; 18(9):1153-61. PubMed ID: 27349698
[TBL] [Abstract][Full Text] [Related]
20. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
